ELAHERE™ (mirvetuximab soravtansine-gynx), FDA Approved for Platinum-Resistant Ovarian Cancer, Available at Biologics by McKesson
Biologics by McKesson became the sole specialty pharmacy provider for ELAHERE, approved for adults with FRα-positive, platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer.